PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
      Google Scholar   
Citation:
Annals of Oncology vol 31 (Supplement 4) S1145
Meeting Instance:
ESMO 2020
Year:
2020
Type:
Abstract
Sub type:
Published Only
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
3408  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer, Inc.  
Grants:
 
Corr. Author:
 
Authors:
                                         
Networks:
 
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: